HRT Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
HRT Financial's JAZZ Position: Q2 2026 in Review
HRT Financial increased its Jazz Pharmaceuticals (JAZZ) stake by 197% in Q2 2026, buying an estimated $4.85M and bringing the position to 33,361 shares worth $8.04M. The position accounts for 0.01% of the portfolio, ranked #880.
HRT Financial first reported a position in JAZZ in Q2 2019 and has held it in 15 quarters since. The position peaked at $14.7M in Q1 2025. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- HRT Financial held 33,361 shares of Jazz Pharmaceuticals worth $8.04M as of Q2 2026.
- HRT Financial bought 22,134 Jazz Pharmaceuticals shares in Q2 2026, an estimated $4.85M.
- Jazz Pharmaceuticals made up 0.01% of HRT Financial's portfolio in Q2 2026, its #880 holding.
- HRT Financial first reported a position in Jazz Pharmaceuticals in Q2 2019 and has held it in 15 quarters since.
- HRT Financial's Jazz Pharmaceuticals position peaked at $14.7M in Q1 2025.
- 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.